Profit

Buy Aurobindo pharma, Divis Lab, Alembic pharma: IndiaNivesh

PUBLISHED ON: June 7, 2012 | Duration: 35 min, 13 sec

  
loading..
Daljeet Kohli, Head- Research at IndiaNivesh Securities, Jigar Lodaya, AVP at Sharekhan, Paras Adenwala, Investment Advisor and Phani Sekhar, Fund Manager PMS at Angel Broking discuss the stock markets. Daljeet Kohli advises investors to buy Alembic pharma with target of Rs 79, Aurobindo pharma with target of Rs 150 and Divis lab stocks with a target of Rs 1032 per share.
ALSO WATCH
Sensex Slides Over 1,000 Points As New Covid Variant Spooks Investors

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com